Mahdavinia Masoud, Khorsandi Layasadat, Alboghobeish Soheila, Samimi Azin, Dehghani Mohammad Amin, Zeidooni Leila
Toxicology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Cellular and Molecular Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Avicenna J Phytomed. 2021 Jul-Aug;11(4):394-406. doi: 10.22038/AJP.2021.17649.
Bisphenol A (BPA) is an organic synthetic compound, often used in manufacturing polycarbonate plastics. Researches have shown the role of BPA as an endocrine disruptor. The present study intended to evaluate the hepatoprotective properties of naringin, an active flavanone glycoside present in many citrus fruit, against hepatotoxicity induced by BPA.
Male Wistar rats were orally treated with 50 mg/kg BPA for 30 consecutive days for induction of toxicity and 40, 80 and 160 mg/kg naringin for the same period along with BPA or alone.
This study demonstrated that BPA significantly increased serum levels of triglyceride, lactate dehydrogenase (LDH), alkaline phosphatase (ALP), lipid peroxidation, and aspartate aminotransferase (AST) and significantly reduced catalase, glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity, glutathione (GSH) and caused periportal inflammation and microvesicular steatosis in rat tissue. However, BPA did not change serum levels of high-density lipoprotein-cholesterol (HDL-C), total cholesterol, alanine aminotransferase (ALT), or low-density lipoprotein-cholesterol (LDL-C). Furthermore, the results displayed that administration of 80 and 160 mg/kg naringin improved hepatotoxicity and altered lipid peroxidation level, serum values of triglyceride and liver enzymes, and oxidative stress factors that were induced by BPA. The effect of two doses of 80 and 160 mg/kg naringin was more noticeable than that of dose 40 mg/kg.
The findings suggested the protective effects of naringin against BPA-induced hepatotoxicity via ameliorating liver histopathological alteration, suppressing oxidative stress and lipid-lowering properties.
双酚A(BPA)是一种有机合成化合物,常用于制造聚碳酸酯塑料。研究表明BPA具有内分泌干扰物的作用。本研究旨在评估柚皮苷(一种存在于多种柑橘类水果中的活性黄烷酮糖苷)对BPA诱导的肝毒性的肝保护特性。
雄性Wistar大鼠连续30天口服50mg/kg BPA以诱导毒性,同时在同一时期口服40、80和160mg/kg柚皮苷,可与BPA一起服用或单独服用。
本研究表明,BPA显著提高了血清甘油三酯、乳酸脱氢酶(LDH)、碱性磷酸酶(ALP)、脂质过氧化以及天冬氨酸转氨酶(AST)的水平,并显著降低了过氧化氢酶、谷胱甘肽过氧化物酶(GPx)和超氧化物歧化酶(SOD)的活性、谷胱甘肽(GSH),并在大鼠组织中引起门周炎症和微泡性脂肪变性。然而,BPA并未改变血清高密度脂蛋白胆固醇(HDL-C)、总胆固醇、丙氨酸转氨酶(ALT)或低密度脂蛋白胆固醇(LDL-C)的水平。此外,结果显示,给予80和160mg/kg柚皮苷可改善肝毒性,并改变脂质过氧化水平、甘油三酯血清值和肝酶以及由BPA诱导的氧化应激因子。80和160mg/kg这两个剂量的柚皮苷的效果比40mg/kg剂量更显著。
研究结果表明柚皮苷通过改善肝脏组织病理学改变、抑制氧化应激和降低血脂特性,对BPA诱导的肝毒性具有保护作用。